Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma

Autor: Akkök, Çiğdem Akalin, Hervig, Tor, Stamnesfet, Siren, Nesthus, Ingerid, Melve, Guro K., Lassalle, Philippe, Bruserud, Øystein ^*

Publikováno v: In Cytotherapy November 2011 13(10):1259-1268

Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial

Autor: Gimsing, Peter, Carlson, Kristina, Turesson, Ingemar, Fayers, Peter, Waage, Anders, Vangsted, Annette, Mylin, Anne, Gluud, Christian, Juliusson, Gunnar, Gregersen, Henrik, Hjorth-Hansen, Henrik, Nesthus, Ingerid, Dahl, Inger Marie S, Westin, Jan, Nielsen, Johan Lanng, Knudsen, Lene Meldgaard, Ahlberg, Lucia, Hjorth, Martin, Abildgaard, Niels, Andersen, Niels Frost, Linder, Olle, Wisløff, Finn

Publikováno v: In Lancet Oncology 2010 11(10):973-982

A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia

Autor: Gruber, Astrid, Björkholm, Magnus, Brinch, Lorentz, Evensen, Stein, Gustavsson, Bengt, Hedenus, Michael, Juliusson, Gunnar, Löfvenberg, Eva, Nesthus, Ingerid, Simonsson, Bengt, Sjo, Malvin, Stenke, Leif, Tangen, Jon Magnus, Tidefelt, Ulf, Udén, Ann-Mari, Paul, Christer, Liliemark, Jan

Publikováno v: In Leukemia Research 2003 27(4):323-328

Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial

Autor: Mellqvist, Ulf-Henrik Mellqvist, Westin, Jan, Gimsing, Peter, Hjertner, Oyvind, Lenhoff, Stig, Laane, Edward, Remes, Kari, Steingrimsdottir, Hlif, Abildgaard, Niels, Ahlberg, Lucia, Carlsson, Kristina, Dahl, Inge Marie, Forsberg, Karin, Gedde-Dahl, Tobias, Gregersen, Henrik, Gruber, Astrid, Guldbrandsen, Nina, Haukås, Einar, Linder, Olle, Nahi, Hareth, Nesthus, Ingerid, Clausen, Nielsaage Tøffner, Silvennoinen, Raija, Andersen, Niels Frost, Turesson, Ingemar, Waage, Anders

Publikováno v: Mellqvist, U-H M, Westin, J, Gimsing, P, Hjertner, O, Lenhoff, S, Laane, E, Remes, K, Steingrimsdottir, H, Abildgaard, N, Ahlberg, L, Carlsson, K, Dahl, I M, Forsberg, K, Gedde-Dahl, T, Gregersen, H, Gruber, A, Guldbrandsen, N, Haukås, E, Linder, O, Nahi, H, Nesthus, I, Clausen, N T, Silvennoinen, R, Andersen, N F, Turesson, I & Waage, A 2009, ' Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial. ', Blood .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::58461dca0ae05f89893e9372c9050d5b
https://pure.au.dk/portal/da/publications/improved-response-rate-with-bortezomib-consolidation-after-high-dose-melphalan-first-results-of-a-nordic-myeloma-study-group-randomized-phase-iii-trial(e1db5290-067d-11df-b95d-000ea68e967b).html

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.